BEAM icon

Beam Therapeutics
BEAM

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$32
11% downside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
UBS
UBS
Michael Yee
7 Jan ‘26 7 days ago
Evercore ISI Group
Evercore ISI Group
Cory Kasimov
100% 1-yr BEAM win rate
24 Nov ‘25 1 month ago